NCT00415428View on ClinicalTrials.gov

A Quality Ensuring Project With Focus On Patients With Cardiovascular Diseases As Well As Type 2 Diabetes.

CompletedOBSERVATIONAL
Enrollment

2,776

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Heart DiseasesDiabetes Mellitus, Type 2
Interventions
BEHAVIORAL

Patient adherence to national educational guidelines.

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00415428 - A Quality Ensuring Project With Focus On Patients With Cardiovascular Diseases As Well As Type 2 Diabetes. | Biotech Hunter | Biotech Hunter